Targeting HIV-1 RNase H: N’-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants
Sign Up to like & getrecommendations! Published in 2020 at "Viruses"
DOI: 10.3390/v12070729
Abstract: HIV-1 infection requires life-long treatment and with 2.1 million new infections/year, faces the challenge of an increased rate of transmitted drug-resistant mutations. Therefore, a constant and timely effort is needed to identify new HIV-1 inhibitors… read more here.
Keywords: inhibitor; rnase; hydroxy benzylidene; resistant variants ... See more keywords